EPV Sensors

Executive Summary

EPV Sensors is a San Diego-based medical device company developing a proprietary non-invasive sensor technology for continuous measurement of intraocular pressure (IOP). Elevated IOP is the primary modifiable risk factor for glaucoma, a leading cause of irreversible blindness worldwide. Current IOP measurement methods are intermittent and require clinical visits, missing critical pressure fluctuations. EPV Sensors' platform aims to enable at-home, real-time IOP monitoring, potentially improving disease management and preventing vision loss. The technology leverages advanced sensing mechanisms to achieve accuracy comparable to invasive methods while being comfortable for daily use. The company was founded in 2015 and remains in a pre-revenue stage, focusing on product development and early validation. While specific funding and regulatory milestones are not publicly disclosed, the addressable market is substantial given the prevalence of glaucoma (over 80 million patients globally). Key challenges include demonstrating clinical accuracy, securing FDA clearance, and scaling manufacturing. If successful, EPV Sensors could transform glaucoma care by enabling proactive treatment adjustments, reducing the burden on healthcare systems, and improving patient outcomes.

Upcoming Catalysts (preview)

• Q4 2026Completion of First-in-Human Feasibility Study70% success
• Q2 2027Strategic Partnership or Licensing Deal with Ophthalmic Device Company50% success
• Q3 2026FDA Breakthrough Device Designation60% success